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Introduction
Wound care is a growing industry that lately has been facing multiple
challenges due to the increasing health care costs, aging of population,
appearance of antibiotic-resistant pathogens, and rise in the incidence
of chronic diseases. Unlike acute wounds which heal in a predictable
amount of time following the stages of healing, chronic wounds (CW)
often fail to progress past the inflammatory phase, increasing costs and
healing time. Bioactive dressings that incorporate drugs/antibiotics or
bioactive molecules in their formulation have been suggested as
alternatives to the conventional gauzes and foams. Here, we propose
the combination of poly(vinyl alcohol) (PVA) and cellulose acetate (CA),
both biodegradable and biocompatible polymers, for the production of
films processed via a new method that combines principles from solvent
casting and phase inversion, and modified with the antimicrobial peptide
(AMP) LL37, as a new active solution.
PVA/CA Film Production
Materials: PVA, Mw 72,000 and 88% hydrolyzed, and Ca, Mn 30,000
and 39.8wt.% acetyl groups; dimethyl formamide (DMF) as solvent;
coagulation bath of sodium sulfate (Na2SO4) and sodium hydroxide
(NaOH)
Method: Solvent Casting followed by Phase-Inversion
PVA/CA Films Characterization
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2) Tensile Strength, Elongation, Porosity and Swelling
*Paper-like consistency, unable to explore mechanically.
LL37 Functionalization
“Graft to” methodology using poly(dopamine) (pDOPA) as binding
agent. Vancomycin was used as control antibiotic.
Antimicrobial Action
Shake Flask Method (ASTM-E2149-01)




Plasma + 1M CaCl2 at
20 mM (37ºC)
Conclusions: The potential of LL37 functionalized PVA/CA films for
prospective wound-healing applications was demonstrated.













100 PVA 3.24 ± 0.03 253.53 ± 26.99 29.07 ± 5.12 89.87 ± 0.95
90/10 2.56 ± 0.14 247.00 ± 47.27 30.90 ± 2.43 89.26 ± 0.47
80/20 2.52 ± 0.25 244.47 ± 23.26 33.40 ± 3.79 88.35 ± 0.85
70/30 1.49 ± 0.18 244.20 ± 39.78 37.52 ± 6.81 88.12 ± 0.79
60/40 1.48 ± 0.15 222.13 ± 48.87 44.92 ± 2.15 89.01 ± 0.56
50/50 1.28 ± 0.20 201.87 ± 41.17 52.99 ± 4.95 89.21 ± 1.15
100 CA* - - 91.83 ± 14.62 89.62 ± 1.00
AMP detected ≈ 56 ug/mL
21.6 ± 2.5 µg/cm2
(detected by sulfo-SDTB)
- More than 50% of AMP immobilized and 
available for recognition 
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